HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Modulation of apoptosis by endogenous Bcl-xL expression in MKN-45 human gastric cancer cells.

Abstract
This study was designed to clarify the role of endogenous Bcl-xL expression in modulating apoptosis of malignant cells. Administration of bcl-x-antisense oligonucleotides decreased Bcl-xL protein levels in the MKN-45 human gastric cancer cell line. The decrease in Bcl-xL protein content resulted in increased cell death induced by serum deprivation or Fas-antibody administration. Flow cytometric analysis revealed that the increased apoptotic cell death was more prominent in bcl-x-antisense-treated cells as compared to control cells, bcl-x-sense-treated cells, or bcl-x-nonsense-treated cells. To inhibit the effect of intrinsic Bcl-xL protein, we overexpressed Bak, which binds Bcl-xL and inhibits the anti-apoptotic effect of Bcl-xL, by transfection into MKN-45 cells. Bak-overexpressing cells showed increased apoptotic cell death induced by Fas-antibody when compared to parent cells and MKN-neo-transfected cells. Bak-overexpressing cells also showed greater sensitization to 5-fluorouracil and cisplatin than parent cells and MKN-neo-transfected cells. In conclusion, we demonstrated that administration of bcl-x-antisense oligonucleotides or overexpression of Bak protein induces sensitization to apoptosis in MKN-45 gastric cancer cells, suggesting that endogenous Bcl-xL expression in cancer cells is an important modulator of apoptosis.
AuthorsS Kondo, Y Shinomura, S Kanayama, Y Higashimoto, T Kiyohara, S Zushi, S Kitamura, H Ueyama, Y Matsuzawa
JournalOncogene (Oncogene) Vol. 17 Issue 20 Pg. 2585-91 (Nov 19 1998) ISSN: 0950-9232 [Print] England
PMID9840921 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • BAK1 protein, human
  • BCL2L1 protein, human
  • Culture Media, Serum-Free
  • Membrane Proteins
  • Neoplasm Proteins
  • Oligonucleotides, Antisense
  • Proto-Oncogene Proteins c-bcl-2
  • Recombinant Fusion Proteins
  • bcl-2 Homologous Antagonist-Killer Protein
  • bcl-X Protein
  • fas Receptor
  • Cisplatin
  • Fluorouracil
Topics
  • Antibodies, Monoclonal (pharmacology)
  • Antineoplastic Agents (pharmacology)
  • Apoptosis (genetics)
  • Cisplatin (pharmacology)
  • Culture Media, Serum-Free
  • Fluorouracil (pharmacology)
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Membrane Proteins (genetics, physiology)
  • Neoplasm Proteins (physiology)
  • Oligonucleotides, Antisense (pharmacology)
  • Proto-Oncogene Proteins c-bcl-2 (genetics, physiology)
  • Recombinant Fusion Proteins (physiology)
  • Stomach Neoplasms (genetics, metabolism, pathology)
  • Tumor Cells, Cultured (drug effects)
  • bcl-2 Homologous Antagonist-Killer Protein
  • bcl-X Protein
  • fas Receptor (immunology, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: